|
Altea Therapeutics has developed an advanced drug delivery system that allows a wide variety of drugs and vaccines across the skin. This breakthrough should improve the efficacy, safety and compliance of drugs and vaccines. Co-investors: Domain Associates, Venrock Associates, vSpring Capital www.alteatherapeutics.com |
||
|
Avedro has developed innovative ophthalmology solutions for the Lasik and myopia markets. Co-investors: Prism Ventures, De Novo Ventures, Flagship Ventures www.avedro.com |
||
 |
Cameron Health is developing a novel implantable cardioverter defibrillator that is easier to implant and has no intravenous leads. Co-investors: Three Arch Partners, Versant Ventures, Delphi Ventures www.cameronhealth.com | ||
 |
Cardiocore Lab, Inc. advances the quality and speed of clinical trials by providing the world’s finest cardiac testing services. Centralized services include ECG analysis, Holter monitoring, protocol design and statistical analysis.
Co-investors: Caxton Health www.cardiocorelab.com |
||
 |
CardioMEMS, Inc. is a medical device company that develops wireless medical pressure sensors. The technology platform is initially designed to improve the management of severe cardiovascular diseases such as heart failure and aneurysms.
Co-investors: St. Jude Medical, Boston Millenia, Arcapita Ventures, Foundation Medical www.cardiomems.com |
||
 |
Ception Therapeutics, Inc. is an emerging biopharmaceutical company discovering and developing novel biologic and small-molecule agents to address unmet medical needs. The company has late-stage biologic anti-inflammatory programs, a small molecule anti-TNF program and several other discovery programs. Acquired by Cephalon Co-investors: Essex Woodlands, MDS Capital, Investor Growth Capital www.ceptiontx.com |
||
 |
Concerro
is an IT company focused on providing flexible
workforce management solutions for the healthcare
industry. The company’s lead offering is a
software system that enables facilities to create
and manage an internal registry for nurses and
other clinical staff, providing significant ROI
for the facilities and flexibility and increased
income for the staff.
Co-investors: Kaiser Ventures, Himalaya Capital, RK Ventures www.concerro.com |
||
 |
Conor Medsystems is a medical device company that develops stents and other medical devices as delivery platforms for controlled local delivery of a wide variety of therapeutic agents. Its proprietary technologies enable the delivery of multiple drugs or biotech compounds to various sites in the body.
NASD: CONR Acquired by Johnson & Johnson Co-investors: Easton Capital, Highland Capital, Maverick Capital www.conormed.com |
||
|
Entrigue Surgical is a medical device company developing innovative treatment options within the underserved Ears, Nose and Throat markets.
Co-investors: The Vertical Group, Prism Ventures www.entriguesurgical.com |
||
 |
Interlace Medical is a medical device company developing minimally invasive treatment options in the field of women's health. Acquired by Hologic Co-investors: New Leaf, Spray, Baird, HLM www.interlacemedical.com |
||
 |
Mako Surgical is a medical device
company that is developing advanced technologies and
procedures for the rapidly emerging orthopedic
minimally invasive total joint market.
NASD: MAKO Co-investors: MDS Capital, Skyline, Montreux, Alta, Exxel Group www.makosurgical.com |
||
 |
Redpoint
Bio is a biotechnology company that has made breakthroughs in the science of taste: the elimination of the perception of bitterness and the enhancement of the sweetness of natural sugar. These breakthroughs can potentially be used extensively in the pharmaceutical and food and beverage industries. The product line will consist of natural compounds that will have their desired effects when mixed with the target products.
OTCBB: RPBC Co-investors: Cargill Ventures, NJTC Ventures, SR One www.redpointbio.com |
||
 |
TherOx
developed its SuperSaturated Oxygen Therapy to treat
ischemic tissues and conditions.
Using the TherOx technology, hyperbaric levels of
oxygen can be delivered to the heart to salvage
tissue affected by acute myocardial infarction. This is the first of many
applications for TherOx’s technology platform.
Co-investors: Kleiner Perkins, DAG Ventures, Integral Capital, New Science Ventures, Wasatch Ventures www.therox.com |
||
 |
TransMolecular is a biotechnology company that has discovered and developed a novel tumor targeting platform. The company’s technology may enable more effective and safer cancer treatment options.
Acquired by Eisai Co-investors: Easton Capital, Tullis Dickerson, TVM Capital www.transmolecular.com |
||
 |
Xlumena is a medical device company developing innovative treatment options within the interventional gastroenterology markets.
Co-investors: Prism Ventures, Charter Life Sciences, Ascent Biomedical www.xlumena.com |
||
 |
Yaupon Therapeutics is a specialty pharmaceutical company whose lead product is a gel formulation of a drug for a type of cutaneous T-cell lymphoma.
Co-investors: Vivo Ventures, Palo Alto Investors www.yaupontherapeutics.com |
